“The FDA Unexpected emergency Use Authorization of molnupiravir is an important milestone from the combat against COVID-19, and adds to Merck’s legacy of bringing ahead revolutionary medicines that both equally tackle the world’s biggest wellbeing threats and help preserve life. Since we identified the promise of molnupiravir early, Merck invested https://cf5359135.csublogs.com/34091395/manual-article-review-is-required-for-this-article